Brown Shipley & Co
BIIB icon

Brown Shipley & Co’s Biogen BIIB Stock Holding History

Brown Shipley & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.2K Hold
85
– – 0.01% 69
2026
Q2 		$18.4K Hold
85
– – 0.01% 67
2026
Q1 		$15.6K Hold
85
– – 0.01% 68
2025
Q4 		$15K Hold
85
– – 0.01% 65
2025
Q3 		$11.9K Hold
85
– – 0.01% 61
2025
Q2 		$10.7K Sell
85
-22
-21% -$2.74K 0.01% 64
2025
Q1 		$14.6K Buy
107
+85
+386% +$12.2K 0.01% 61
2024
Q4 		$3.36K Sell
22
-26
-54% -$4.38K ﹤0.01% 65
2024
Q3 		$9.3K Sell
48
-52
-52% -$10.9K ﹤0.01% 66
2024
Q2 		$23.2K Hold
100
– – 0.01% 65
2024
Q1 		$21.5K Sell
100
-121
-55% -$28.3K 0.01% 90
2023
Q4 		$57.2K Sell
221
-511
-70% -$126K 0.03% 67
2023
Q3 		$188K Sell
732
-102
-12% -$27.3K 0.1% 55
2023
Q2 		$238K Sell
834
-27
-3% -$8.04K 0.1% 62
2023
Q1 		$239K Buy
+861
New +$238K 0.15% 54

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Brown Shipley & Co's BIIB Position: Q3 2026 in Review

Brown Shipley & Co held its Biogen (BIIB) position steady in Q3 2026 at 85 shares worth $19.2K. The position accounts for 0.01% of the portfolio, ranked #69.

Brown Shipley & Co first reported a position in BIIB in Q1 2023 and has held it in 15 quarters since. The position peaked at $239K in Q1 2023. 643 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Brown Shipley & Co held 85 shares of Biogen worth $19.2K as of Q3 2026.
  • Brown Shipley & Co left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.01% of Brown Shipley & Co's portfolio in Q3 2026, its #69 holding.
  • Brown Shipley & Co first reported a position in Biogen in Q1 2023 and has held it in 15 quarters since.
  • Brown Shipley & Co's Biogen position peaked at $239K in Q1 2023.
  • 643 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Brown Shipley & Co's 13F filing for Q3 2026, filed 9 Oct 2026.